|
Oct 18
|
TME Pharma Reports H1 2024 Financial Results and Provides Business and Clinical Update
|
|
Sep 30
|
TME Pharma Announces Appointment of Alexandra Glucksmann to Supervisory Board
|
|
Sep 27
|
TME Pharma Provides Results of Third Exercise of Warrants Z
|
|
Aug 27
|
TME Pharma Announces Convocation of an Extraordinary General Meeting of Shareholders
|
|
Jan 9
|
TME Pharma Announces Successful Advice Meeting With US Food and Drug Administration on NOX-A12 Development in Brain Cancer
|